De Cock K M, Fowler M G, Mercier E, de Vincenzi I, Saba J, Hoff E, Alnwick D J, Rogers M, Shaffer N
Division of HIV/AIDS Prevention-Surveillance and Epidemiology, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
JAMA. 2000 Mar 1;283(9):1175-82. doi: 10.1001/jama.283.9.1175.
Each year, an estimated 590,000 infants acquire human immunodeficiency virus type 1 (HIV) infection from their mothers, mostly in developing countries that are unable to implement interventions now standard in the industrialized world. In resource-poor settings, the HIV pandemic has eroded hard-won gains in infant and child survival. Recent clinical trial results from international settings suggest that short-course antiretroviral regimens could significantly reduce perinatal HIV transmission worldwide if research findings could be translated into practice. This article reviews current knowledge of mother-to-child HIV transmission in developing countries, summarizes key findings from the trials, outlines future research requirements, and describes public health challenges of implementing perinatal HIV prevention interventions in resource-poor settings. Public health efforts must also emphasize primary prevention strategies to reduce incident HIV infections among adolescents and women of childbearing age. Successful implementation of available perinatal HIV interventions could substantially improve global child survival.
据估计,每年有59万婴儿从母亲那里感染1型人类免疫缺陷病毒(HIV),其中大部分发生在无法实施工业化国家现有标准干预措施的发展中国家。在资源匮乏地区,艾滋病疫情侵蚀了在婴幼儿生存方面来之不易的成果。国际环境下的近期临床试验结果表明,如果研究成果能够转化为实际行动,短疗程抗逆转录病毒疗法可显著降低全球范围内的围产期HIV传播。本文回顾了发展中国家母婴HIV传播的现有知识,总结了试验的主要发现,概述了未来的研究需求,并描述了在资源匮乏地区实施围产期HIV预防干预措施所面临的公共卫生挑战。公共卫生工作还必须强调初级预防策略,以减少青少年和育龄妇女中新增的HIV感染。成功实施现有的围产期HIV干预措施可大幅改善全球儿童的生存状况。